Article Correctness Is Author's Responsibility: Drug Designed for Alzheimer’s Disease May Hold Promise for Treating Glioblastoma

The article below may contain offensive and/or incorrect content.

This shows a brain in a lighbulbA class of drugs called BACE1 inhibitors, originally designed to treat Alzheimer's disease, shows potential for the treatment of glioblastoma brain cancer.